APA

Kandolf Sekulovic L., Peris K., Hauschild A., Stratigos A., Grob J., Nathan P., Dummer R., Forsea A., Hoeller C., Gogas H., Demidov L., Lebbe C., Blank C., Olah J., Bastholt L., Herceg D., Neyns B., Vieira R., Hansson J., Rutkowski P., Krajsova I., Bylaite-Bucinskiene M., Zalaudek I., Maric-Brozic J., Babovic N., Banjin M., Putnik K., Weinlich G., Todorovic V., Kirov K., Ocvirk J., Zhukavets A., Kukushkina M., De La Cruz Merino L., Ymeri A., Risteski M. & Garbe C. (20170807). More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. : European journal of cancer (Oxford, England : 1990).

Chicago

Kandolf Sekulovic L, Peris K, Hauschild A, Stratigos A, Grob J-J, Nathan P, Dummer R, Forsea A-M, Hoeller C, Gogas H, Demidov L, Lebbe C, Blank C, Olah J, Bastholt L, Herceg D, Neyns B, Vieira R, Hansson J, Rutkowski P, Krajsova I, Bylaite-Bucinskiene M, Zalaudek I, Maric-Brozic J, Babovic N, Banjin M, Putnik K, Weinlich G, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Kukushkina M, De La Cruz Merino L, Ymeri A, Risteski M and Garbe C. 20170807. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. : European journal of cancer (Oxford, England : 1990).

Harvard

Kandolf Sekulovic L., Peris K., Hauschild A., Stratigos A., Grob J., Nathan P., Dummer R., Forsea A., Hoeller C., Gogas H., Demidov L., Lebbe C., Blank C., Olah J., Bastholt L., Herceg D., Neyns B., Vieira R., Hansson J., Rutkowski P., Krajsova I., Bylaite-Bucinskiene M., Zalaudek I., Maric-Brozic J., Babovic N., Banjin M., Putnik K., Weinlich G., Todorovic V., Kirov K., Ocvirk J., Zhukavets A., Kukushkina M., De La Cruz Merino L., Ymeri A., Risteski M. and Garbe C. (20170807). More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. : European journal of cancer (Oxford, England : 1990).

MLA

Kandolf Sekulovic L, Peris K, Hauschild A, Stratigos A, Grob J-J, Nathan P, Dummer R, Forsea A-M, Hoeller C, Gogas H, Demidov L, Lebbe C, Blank C, Olah J, Bastholt L, Herceg D, Neyns B, Vieira R, Hansson J, Rutkowski P, Krajsova I, Bylaite-Bucinskiene M, Zalaudek I, Maric-Brozic J, Babovic N, Banjin M, Putnik K, Weinlich G, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Kukushkina M, De La Cruz Merino L, Ymeri A, Risteski M and Garbe C. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. : European journal of cancer (Oxford, England : 1990). 20170807.